NASDAQ:BMRA

Biomerica Stock Forecast, Price & News

$3.55
-0.06 (-1.66 %)
(As of 07/27/2021 09:39 AM ET)
Add
Compare
Today's Range
$3.55
$3.55
50-Day Range
$3.46
$4.63
52-Week Range
$3.30
$9.83
Volume2,556 shs
Average Volume174,933 shs
Market Capitalization$43.67 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.72
30 days | 90 days | 365 days | Advanced Chart
Receive BMRA News and Ratings via Email

Sign-up to receive the latest news and ratings for Biomerica and its competitors with MarketBeat's FREE daily newsletter.


Biomerica logo

About Biomerica

Biomerica, Inc., a biomedical technology company, together with its subsidiaries, develops, patents, manufactures, and markets diagnostic and therapeutic products or detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome (IBS) therapy technology and diagnostic-guided therapy that is designed to allow physicians to identify specific foods that when removed from the patient's diet can alleviate the patient's IBS symptoms; Helicobacter pylori products; and develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was founded in 1971 and is headquartered in Irvine, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.58 out of 5 stars

Medical Sector

491st out of 2,218 stocks

Diagnostic Substances Industry

8th out of 38 stocks

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Biomerica (NASDAQ:BMRA) Frequently Asked Questions

Is Biomerica a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biomerica in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Biomerica stock.
View analyst ratings for Biomerica
or view top-rated stocks.

What stocks does MarketBeat like better than Biomerica?

Wall Street analysts have given Biomerica a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Biomerica wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Biomerica's next earnings date?

Biomerica is scheduled to release its next quarterly earnings announcement on Tuesday, September 7th 2021.
View our earnings forecast for Biomerica
.

How were Biomerica's earnings last quarter?

Biomerica, Inc. (NASDAQ:BMRA) announced its earnings results on Thursday, April, 29th. The company reported ($0.15) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.08) by $0.07. Biomerica had a negative trailing twelve-month return on equity of 45.06% and a negative net margin of 61.55%.
View Biomerica's earnings history
.

How has Biomerica's stock price been impacted by COVID-19?

Biomerica's stock was trading at $2.90 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BMRA stock has increased by 22.4% and is now trading at $3.55.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for BMRA?

3 equities research analysts have issued 12-month price targets for Biomerica's stock. Their forecasts range from $10.00 to $13.00. On average, they expect Biomerica's stock price to reach $11.33 in the next year. This suggests a possible upside of 219.2% from the stock's current price.
View analysts' price targets for Biomerica
or view top-rated stocks among Wall Street analysts.

Who are Biomerica's key executives?

Biomerica's management team includes the following people:
  • Mr. Zackary S. Irani, Chairman & CEO (Age 55, Pay $136.61k)
  • Mr. Allen C. Barbieri, Exec. Vice-Chairman & Corp. Sec. (Age 63, Pay $7.5k)
  • Mr. Steven Sloan, Chief Financial Officer (Age 51)

Who are some of Biomerica's key competitors?

What other stocks do shareholders of Biomerica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biomerica investors own include Sorrento Therapeutics (SRNE), Pfizer (PFE), Johnson & Johnson (JNJ), Ampio Pharmaceuticals (AMPE), OPKO Health (OPK), TG Therapeutics (TGTX), Advanced Micro Devices (AMD), Co-Diagnostics (CODX), FuelCell Energy (FCEL) and Trevena (TRVN).

What is Biomerica's stock symbol?

Biomerica trades on the NASDAQ under the ticker symbol "BMRA."

How do I buy shares of Biomerica?

Shares of BMRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Biomerica's stock price today?

One share of BMRA stock can currently be purchased for approximately $3.55.

How much money does Biomerica make?

Biomerica has a market capitalization of $43.67 million and generates $6.69 million in revenue each year. The company earns $-2,340,000.00 in net income (profit) each year or ($0.23) on an earnings per share basis.

How many employees does Biomerica have?

Biomerica employs 65 workers across the globe.

What is Biomerica's official website?

The official website for Biomerica is www.biomerica.com.

Where are Biomerica's headquarters?

Biomerica is headquartered at 17571 Von Karman Avenue, Irvine CA, 92614.

How can I contact Biomerica?

Biomerica's mailing address is 17571 Von Karman Avenue, Irvine CA, 92614. The company can be reached via phone at (949) 645-2111.


This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.